Assessment of patients’ knowledge and practices regarding their medication use and risks in Lebanon
- 267 Downloads
Background Patients’ knowledge of their medications play a pivotal role in their disease management. Objective Assess the knowledge and practices of Lebanese outpatients regarding their own medication use and risks. Setting Four hundred and sixty community pharmacies across Lebanon. Method It was a cross-sectional study performed from March through May 2016 among Lebanese outpatients, using a self-administered questionnaire. Descriptive statistics were used to calculate all participants’ responses. The association between categorical variables were evaluated using Pearson χ2 test or Fisher’s exact test. Binary logistic regressions were performed to identify factors associated with medication patients’ knowledge and interest. Main outcome measure Ability of the patients to identify own medications’ elements: name, strength, dosage regimen, indication, and adverse drug reactions. Results Our study comprised 921 patients, with around 16% taking ≥5 medications/day. Around 56% of our patients showed sub-optimal medication knowledge. Patients’ higher educational level, number of chronic diseases, and patient physician interaction were associated with higher medication knowledge. Many patients admitted not discussing their medications each time they visit their physicians (38.7%); not reading the leaflet of each medication they take (61.2%); and not regularly asking their pharmacist about the potential interactions of OTC drugs with prescribed medications (53.9%). Conclusion This study showed suboptimal medication-related knowledge, and suboptimal patient’s interactions with primary care givers. Our findings serve as a platform for healthcare providers to understand patients’ needs and educate them about medication use and risks.
KeywordsAdverse drug reactions Community pharmacies Knowledge Lebanon Medication Outpatients
We would like to thank all the inspectors of the OPL for their help in passing the surveys and data entry. We would also like to thank all the members of the OPL Medication Safety Subcommittee, namely: Aline Hajj, Hadi Sherri, Hayat Azouri, Hind Hajj, Maryam Ghorayeb, Marwan Akel, Nouhad Sarkis, and Patricia Shuhaiber.
No sources of funding were used to assist in the preparation of this study.
Conflicts of interest
The authors of this manuscript declare no conflicts of interest.
- 1.Cox A. Involving patients in reporting adverse drug reactions should be welcomed. Pharm J. 2009;282:16.Google Scholar
- 10.Leemans L, Heylen N, Quanten A, Deferme S. Consumer study on the use of patient information leaflets. [Article in French]. J Pharm Belg. 2011;4:109–16.Google Scholar
- 13.European Medicines Agency (EMA). Product-information templates. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/document_listing/document_listing_000134.jsp (2016). Accessed 05 Aug 2016.
- 14.U.S. Department of Health and Human Services; Food and Drug Administration; Center for Drug Evaluation and Research (CDER); and Center for Biologics Evaluation and Research (CBER). Guidance: Useful Written Consumer Medication Information (CMI). http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080602.pdf (2006). Accessed 06 Aug 2016.
- 15.National Patient Safety Foundation (NPSF). Ask Me 3: Good Questions for Your Good Health 2016. http://www.npsf.org/?page=askme3. Accessed 07 Aug 2016.
- 27.World Health Organization Regional Office for Europe. Exploring patient participation in reducing health-care-related safety risks. DK-2100 Copenhagen, Denmark; 2013.Google Scholar
- 28.World Fact Book of the United States Central Intelligence Agency. 2016. Lebanon Demographics Profile 2014. http://www.indexmundi.com/lebanon/demographics_profile.html. Accessed 19 Nov 2015.
- 29.Dean AG, Arner TG, Sunki GG, Friedman R, Lantinga M, Sangam S et al. Epi Info™, a database and statistics program for public health professionals. Atlanta: CDC; 2011.Google Scholar
- 32.Raynor K, Knapp P. Do patients see, read and retain the new mandatory medicines information leaflets? Pharm J. 2004;264(7083):268–70.Google Scholar
- 37.Zeenny R., Forecasting the Future of Pharmacy In Lebanon: The Magic Of Numbers, in The Lebanese Order of Pharmacists Pharmacy Day 2016 conference presentation; 2016.Google Scholar